Table 1 Characteristics of all Surveillance, Epidemiology and End Results(SEER) program and in-institute participants, by cancer stages.

From: Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute

 

All patient N = 45904

Stage IA N = 12769

Stage IB N = 6658

Stage IIA N = 3384

Stage IIB N = 3194

StageIIIA N = 6911

Stage IIIB N = 1929

Stage IV n = 11059

Age at diagnosis—median(Range)

70(30,112)

70(30,112)

71(30,97)

69(30,96)

70(31,101)

69(30,96)

69(31,94)

69(30,102)

Age at diagnosis—mean(SD)

68.98(10.0)

69.08(10.0)

70.05(10.30)

68.79(10.43)

69.22(10.22)

68.74(10.41)

68.05(10.75)

68.52(10.98)

Race—Number(%)

 Caucasian

37542(81.8)

10634(83.3)

5464(82.1)

2743(81.1)

2695(84.4)

5568(80.6)

1553(80.5)

8875(80.3)

 African-American

4745(10.3)

1054(8.3)

605(9.1)

338(10.0)

301(9.4)

768(11.1)

256(13.3)

1423(12.9)

 Asian

3627(7.9)

1081(8.5)

589(8.8)

303(9.0)

198(6.2)

575(8.3)

120(6.2)

761(6.9)

Sex—Number(%)

 Male

23244(50.6)

5486(4.3)

3282(49.3)

1803(53.3)

1689(52.9)

3778(54.7)

1099(57.0)

6106(55.2)

 Female

22660(49.4)

7283(5.7)

3376(50.7)

1581(46.7)

1505(47.1)

3132(45.3)

830(43.0)

4953(44.8)

Grade—Number(%)

 Well-differentiated

7456(16.2)

3971(31.1)

1165(17.5)

371(11.0)

525(16.4)

539(7.8)

97(5.0)

788(7.1)

 Moderately-differentiated

18792(40.9)

5696(44.6)

3172(47.6)

1514(44.7)

1312(41.1)

2789(40.4)

692(35.9)

3617(32.7)

 Poorly-differentiated

19183(41.8)

3041(23.8)

2270(34.1)

1466(43.3)

1322(41.4)

3503(50.7)

1118(58.0)

6463(58.4)

 undifferentiated

473(1.1)

61(0.5)

51(0.8)

33(1.0)

35(1.1)

80(1.2)

22(1.1)

191(1.7)

Histology

 Squamous cell carcinoma

15989(34.8)

3266(25.6)

2309(34.7)

1413(41.8)

1358(42.5)

3023(43.7)

1011(52.4)

3608(32.6)

 Adenocarcinoma

29915(65.2)

9497(74.4)

4349(65.3)

1971(58.2)

1835(57.5)

3888(56.3)

918(47.6)

7451(67.4)

Size(cm)—Number(%)

 size ≤ 1 cm

2429(5.3)

1672(13.1)

163(2.4)

61(1.8)

119(3.7)

175(2.5)

27(1.4)

211(1.9)

 1 < size ≤ 2 cm

10987(23.9)

6665(52.2)

1063(16.0)

473(14)

583(18.3)

949(13.7)

156(8.1)

1098(9.9)

 2 < size ≤ 3 cm

10136(22.1)

4431(34.7)

1238(18.6)

674(19.9)

455(14.2

1344(19.4)

237(12.3)

1757(15.9)

 3 < size ≤ 5 cm

12160(26.5)

4194(63.0)

916(27.1)

590(18.5)

2204(31.9)

564(29.2)

3692(33.4)

 5 < size ≤ 7

6446(14.0)

1260(37.2)

748(23.4)

1335(19.3)

549(28.5)

2554(23.1)

 size>7 cm

3746(8.2)

 

699(219)

904(13.1)

396(20.5)

1747(15.8)

Site

 Upper lobe

68.79(10.3)

7691(60.2)

3970(59.6)

1857(54.9)

1955(61.2)

4280(61.9)

1258(65.2)

6705(60.6)

 Middle lobe

68.36(10.8)

786(6.2)

412(6.2)

178(5.3)

143(4.5)

344(5.0)

88(4.6)

534(4.8)

 Lower lobe

69.66(10.4)

4265(3.3)

2206(33.1)

1288(38.1)

1046(32.7)

2077(30.1)

454(23.5)

3343(30.2)

 Main bronchus

65.82(11.2)

27(0.2)

70(1.1)

61(1.8)

50(1.6)

210(3.0)

129(6.7)

477(4.3)

T stage

 T1a

9970(21.7)

8310(65.1)

426(12.6)

546(7.9)

79(4.1)

545(4.9)

 T1b

6317(13.8)

4459(34.9)

451(13.3)

593(8.6)

89(4.6)

725(6.6)

 T2a

11983(26.1)

6658(100)

1230(36.3)

1711(24.8)

203(10.5)

2181(19.7)

 T2b

3579(7.8)

1277(37.7)

392(12.3)

700(10.1)

129(6.7)

1081(9.8)

 T3

7893(17.2)

2802(87.7)

1944(28.1)

238(12.3)

2910(26.3)

 T4

6225(13.6)

1417(20.5)

1191(61.7)

3617(32.7)

N stage

 N0

27734(60.4)

12769(100)

6658

1277(37.7)

2802(87.7)

1109(1.6)

3119(28.2)

 N1

4503(9.8)

2107(62.3)

392(12.3)

965(14.0)

1039(9.4)

 N2

10811(23.6)

5001(45.2)

 N3

2856(6.2)

956(49.6)

1900(17.20)

  1. SD: Standard deviation.